CX-546
CX-546 is an ampakine drug developed by Cortex Pharmaceuticals. It has been proposed as a treatment for schizophrenia. CX-546 was the second drug of note to come out of the Cortex research program, after CX-516, but while it was an improvement over its predecessor in some respects, it still has problems with limited oral bioavailability.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
CX-546
CX-546 is an ampakine drug developed by Cortex Pharmaceuticals. It has been proposed as a treatment for schizophrenia. CX-546 was the second drug of note to come out of the Cortex research program, after CX-516, but while it was an improvement over its predecessor in some respects, it still has problems with limited oral bioavailability.
has abstract
CX-546 es un fármaco ampakina ...... los opioides y barbitúricos.
@es
CX-546 est un médicament ampakine développé par Cortex Pharmaceutique.
@fr
CX-546 is an ampakine drug dev ...... le for commercial development.
@en
CAS number
215923-54-9
FDA UNII code
PV6YEC8983
PubChem
Wikipage page ID
13,839,587
page length (characters) of wiki page
Wikipage revision ID
1,012,886,986
Link from a Wikipage to another Wikipage
CAS number
ChemSpiderID
IUPAC name
IUPHAR ligand
legal US
Investigational New Drug
@en
PubChem
SMILES
C1CCNCC2=CC3=COCCO3
@en
StdInChIKey
LJUNPHMOGNFFOS-UHFFFAOYSA-N
@en
synonyms
CX-546
@en
UNII
PV6YEC8983
@en
Verifiedfields
changed
@en
verifiedrevid
443,493,909
wikiPageUsesTemplate
subject
hypernym
comment
CX-546 es un fármaco ampakina ...... ada de biodisponibilidad oral.
@es
CX-546 est un médicament ampakine développé par Cortex Pharmaceutique.
@fr
CX-546 is an ampakine drug dev ...... limited oral bioavailability.
@en
label
CX-546
@en
CX-546
@es
CX-546
@fr